Journal
JAMA INTERNAL MEDICINE
Volume 181, Issue 9, Pages 1241-1243Publisher
AMER MEDICAL ASSOC
DOI: 10.1001/jamainternmed.2021.2209
Keywords
-
Categories
Ask authors/readers for more resources
This follow-up study explores the relationship between survival and C-reactive protein levels in patients hospitalized with COVID-19 who were treated with tocilizumab.
This follow-up study of the CORIMUNO-TOCI-1 randomized clinical trial examines the association between survival and C-reactive protein levels in patients hospitalized with COVID-19 who were treated with tocilizumab.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
